Why the study?
Despite advances in screening, targeted therapies, and guidelines, patient-related and system-level barriers to timely diagnosis and treatment of pulmonary hypertension persist.
Addressing systemic and patient-level barriers to pulmonary hypertension care through multidisciplinary collaboration, improved provider education, and policy changes is essential to improve timely diagnosis and treatment.
Pulmonary hypertension (PH) comprises a heterogeneous group of disorders characterized by elevated pressure in the pulmonary arteries. Despite advances in awareness, utilization of non‐invasive screening with echocardiography, increasing number of targeted therapies, and evolving clinical guidelines emphasizing referral to PH specialty centers, barriers to timely diagnosis and treatment persist. Key challenges span patient‐related and system‐level domains that hinder the effective diagnosis, management, and treatment of PH, particularly pulmonary arterial hypertension (PAH). In this article, the obstacles to PH care are examined and actionable recommendations are proposed. By integrating patient‐related and system‐level perspectives, this review provides a framework to bridge persistent gaps in PH care delivery in the United States.
No takes yet. Share an insight, caveat, or question.
Morel et al. (2026) conducted a review in Pulmonary hypertension (PH) and pulmonary arterial hypertension (PAH). Systemic and patient-level barriers to care was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: